Aurobindo Pharma acquires US drugmaker for $250M

Aurobindo Pharma acquires US drugmaker for $250M. The acquisition strengthens its presence in the US generics market. Deal valued at $250 million, funded through debt. Expected to enhance product portfolio and revenue streams.

📊 STOCKS: $AUROPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition